|
HS Code |
401880 |
| Product Name | Fenbendazole CPV/EP |
| Appearance | White to off-white crystalline powder |
| Molecular Formula | C15H13N3O2S |
| Molecular Weight | 299.35 g/mol |
| Assay | ≥ 98.0% |
| Solubility | Practically insoluble in water, soluble in dimethyl sulfoxide |
| Melting Point | 233-234°C |
| Pharmacopoeia Standard | CPV/EP (Chinese Veterinary Pharmacopoeia/European Pharmacopoeia) |
| Storage Conditions | Store in a cool, dry place, protected from light |
| Cas Number | 43210-67-9 |
| Application | Anthelmintic agent for veterinary use |
| Synonyms | Fenbendazolum |
As an accredited Fenbendazole CPV/EP factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, opaque plastic container labeled "Fenbendazole CPV/EP," 500 g net weight, tamper-evident seal, batch details and storage instructions printed. |
| Shipping | Fenbendazole CPV/EP is shipped in tightly sealed, moisture-proof containers to maintain product integrity. It is packed according to regulatory guidelines, typically in fiber drums or HDPE containers, with inner double-layer polyethylene bags. Shipments are clearly labeled and handled under cool, dry conditions to ensure stability and safety during transit. |
| Storage | Fenbendazole CPV/EP should be stored in a tightly closed container, protected from light, moisture, and excessive heat. Keep the storage area cool and dry, ideally at a temperature below 25°C (77°F). Store away from incompatible materials, such as strong oxidizing agents. Ensure the area is secure and accessible only to authorized personnel, in accordance with standard pharmaceutical storage guidelines. |
Competitive Fenbendazole CPV/EP prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Dealing with internal parasites in livestock and pets is not something animal owners can afford to take lightly. With rising global demand for safe, healthy animal products, veterinarians and producers look for reliable solutions that can meet both health needs and regulatory standards. Fenbendazole CPV/EP has grown into a cornerstone antiparasitic, meeting expectations on multiple levels.
Fenbendazole has a proven track record among benzimidazole class dewormers. Its CPV/EP designation signals that the product complies with widely accepted pharmacopoeias, specifically the Chinese Pharmacopoeia (CPV) and European Pharmacopoeia (EP). People working with livestock trust these benchmarks because they mean each batch measures up to rigorous quality, purity, and potency standards. From firsthand field observations, this sort of reliability gives animal health professionals confidence to choose Fenbendazole CPV/EP even when cheaper or more obscure alternatives exist.
One thing that stands out about Fenbendazole is its mechanism of action. Instead of attacking parasites from the outside, it interferes with their energy metabolism by binding to beta-tubulin and blocking glucose uptake. Over time, this shuts down their ability to survive and reproduce. Veterinarians appreciate this mode of attack because it targets a wide range of gastrointestinal parasites, including roundworms, hookworms, whipworms, and some tapeworm species. The scope offers clear advantages for large herds or kennel environments where mixed infections run rampant.
Fenbendazole CPV/EP powder typically carries a specification of 98% purity or higher—meaning almost nothing in the package but what helps animals recover faster. Tablet and granule forms often target direct oral dosing, supporting veterinary professionals in tailoring therapy based on animal size and species. A 1-gram tablet of Fenbendazole, produced using CPV/EP criteria, brings clarity to dosing protocols—what you see on the package is exactly what goes into the animal, and that simplifies the math compared to some bulk powders or compounded products shipped without robust assay data.
Over multiple years working with farm clients, I noticed a strong preference for CPV/EP-certified forms. These products dissolve predictably in water or feed rations, easing administration both for single animals and group dosing in feedlots or large kennels. No one wants to deal with sediment or clumping, especially when treating sheep, goats, poultry, or household pets. This practical difference signals real-world value, separating Fenbendazole CPV/EP from older generic benzimidazoles that sometimes show up as inconsistent powders or loose suspensions.
Compliance matters in animal health. Producers who export meat, milk, or eggs to international markets take regulations seriously. Residual drug levels can make or break business—one failed export test can cost millions in lost contracts. Fenbendazole CPV/EP stands out because it’s widely recognized by veterinary authorities and drug regulators in many regions. Reliable clearance data backs up proper withdrawal times, protecting both producers and consumers.
Many veterinarians report excellent tolerability with Fenbendazole-based products. Cases of upset stomach or adverse reactions remain rare, which means less downtime for animals, and less anxiety for owners. Feedback from practicing vets points to another key advantage: Fenbendazole is safe for use in pregnant and lactating animals, when dosed appropriately. This makes it a go-to choice during critical production stages like calving, lambing, or farrowing, where untreated parasitism could decimate animal health and productivity.
Animal health professionals have many options. Most rotate between classes of dewormers to manage resistance, and each product comes with its own strengths and weaknesses. I’ve worked on farms where older products like levamisole or pyrantel remain in rotation. These drugs handle some parasite burdens well, but tend to carry higher toxicity risks in stressed or young animals. Ivermectin, the classic macrocyclic lactone, often enters the discussion, especially for external parasites or harder-to-reach species. Yet, resistance problems are mounting globally.
What sets Fenbendazole CPV/EP apart is its broad-spectrum action and relatively slow resistance development, especially compared to the macrocyclic lactones. Overuse of any anthelmintic drives resistance, but field surveys and laboratory tests continue to show Fenbendazole holding strong in many systems, especially when owners rotate it appropriately. During outbreaks of coccidiosis or combined parasite loads, Fenbendazole-based regimens frequently finish the job, where single-mode dewormers leave gaps. The safety profile for both food and companion animals helps explain its staying power.
Some farmers favor “natural” dewormers—herbal preparations, essential oils, or dietary changes. My experience, and the published data, point toward inconsistent outcomes at best. While these options serve as an adjunct or preventive measure, they rarely replace a pharmaceutical-grade solution during a heavy parasite challenge. By contrast, Fenbendazole CPV/EP offers lab-verified effectiveness, precise dosing, and a clean safety record, giving animal owners insurance against losses and setbacks from recurring infestations.
I remember one season working on a sheep farm where periodic outbreaks of Haemonchus contortus—also known as barber pole worm—created chaos. Lambs lost weight, wool quality dropped, and spontaneous mortalities piled up. The farm had tinkered with diet changes and alternative products, but only achieved temporary relief. Once the transition to Fenbendazole CPV/EP occurred, along with rotation planning, lamb losses fell sharply. Fecal egg counts dropped with each round of treatment, and owner stress melted away. After seeing these results across multiple herds and species, it’s hard to overestimate the peace of mind that comes with a well-formulated dewormer that “just works” when the pressure is on.
I’ve heard similar stories from kennel operators and horse stables, each facing the yearly grind of keeping parasite loads manageable. Here, having a CPV/EP-certified supply means less second-guessing about hidden inactive ingredients or variability from one batch to the next. That’s part of earning trust in animal health supply chains, especially with so much at stake for food safety and animal welfare.
No one should treat parasite management as a one-time fix. Resistance management stands as one of the biggest hurdles for the industry. The best results in reducing resistance come from strategic use. Rotating between drug classes, monitoring fecal egg counts, and dosing only when problem thresholds appear—all lower unnecessary exposure and keep products like Fenbendazole CPV/EP effective.
Smart programs avoid blanket dosing of every animal. Diagnostics, such as the FAMACHA system for sheep, have shifted the focus toward selective treatment. Groups most at risk, such as young, pregnant, or high-producing animals, benefit from intervention, while the rest of the herd avoids excess drug exposure.
Another essential practice: dosing based on current, accurate weights. Underdosing remains the leading contributor to resistance. With clear specifications on Fenbendazole CPV/EP packaging, it’s straightforward to match the exact dose to the animal’s size, avoiding the pitfalls seen with less reliable product sources.
Pet owners face challenges that often parallel those of livestock producers. Intestinal parasites pass easily between animals in crowded shelters or busy parks. Deworming protocols in dogs and cats draw from the same science used in farm settings, though individual attention becomes easier for small animals. Fenbendazole CPV/EP’s safety profile—well-documented in studies and everyday use—makes it an easy recommendation for puppies, kittens, and adults, including during pregnancy.
I’ve worked with rescue groups worried about hard-to-control outbreaks of giardia or recurring roundworm infestations. In these cases, Fenbendazole CPV/EP—available as a suspension, powder, or tablet—brings reliable performance over multi-day regimens, with minimal side effects. Families and shelter workers alike appreciate being able to trust the quality behind the label, especially compared to generic alternatives sold online without reference to recognized standards.
Governments and consumer groups keep a watchful eye on antiparasitic use in food animals. Product recalls, export bans, and consumer backlash follow poor oversight. Fenbendazole CPV/EP occupies a strong position because international authorities—including veterinary associations and regulatory agencies—recognize its profile and establish accepted withdrawal periods. With documented depletion studies and robust surveillance programs, producers avoid surprises when meat, milk, or eggs reach the market.
In practice, clear guidance on withdrawal timelines reduces risk. Using CPV/EP-standard products means producers don’t stagger in the dark, guessing about residuals and legal compliance. These clear lines foster trust throughout the food system—from the farmer to the end consumer in the grocery aisle.
Parasite resistance does not stand still. Across regions, researchers see growing signs of resistance even in benzimidazole drugs. The lesson isn’t to abandon effective tools, but to use them with intention and good records. Investing in regular fecal analysis, whole-herd monitoring, and targeted treatments helps keep Fenbendazole CPV/EP effective over the long term.
Technological advances may deliver innovative formulations—slow-release boluses, improved suspensions, or new combinations with probiotics and vaccines. Still, the foundational reliability of CPV/EP-standard fenbendazole sets a benchmark. It gives veterinarians and producers a stable anchor, letting them incorporate new research without losing the hard-won gains of parasite control.
People managing herds or family pets benefit most when they work with veterinarians to design integrated parasite programs. Tracking when and how treatments have been given, measuring outcomes, and limiting unnecessary exposure keep both animal health and product effectiveness high. For farms, regular animal weighing and batch tracking pay off, as clear dosing and withdrawal help pass every audit and regulatory screen.
Pet owners should follow veterinary advice on dosing intervals and watch for any signs of intolerance. Keeping an open line to local clinics ensures prompt intervention if needed, and supports ongoing research by reporting outcomes and resistance trends.
Across decades, animal welfare has improved as affordable, effective treatments reach more communities. From large commercial farms to small family operations and household pets, having a dependable, transparent product makes a difference. Fenbendazole CPV/EP stands as a trusted ally—supported by science, favored by professionals, and anchored in internationally recognized standards.
Those operating at the intersection of animal well-being and public health must prioritize more than just price or convenience. History shows that cheap, unstandardized products open the door to resistance, ineffective treatment, and lost consumer trust. The path forward stays clearest when built on robust products like Fenbendazole CPV/EP, paired with data-driven management and ongoing education.
Parasite challenges will keep evolving, but consistent quality delivers the resilience animal owners need. Fenbendazole CPV/EP doesn’t pretend to fix every challenge, but it lets veterinarians, producers, and pet owners focus on animal health, confident that the core tool in their kit remains sharp and ready.